Stock Price Targets and Analyst Ratings

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
ABDN abrdn	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 176 +1.8%	GBX 140 ➝ GBX 172	Neutral
ADUR Aduro Clean Technologies	Initiated by	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jesse Sobelson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$5.27 +3.5%	$50.00	Buy
AEM Agnico Eagle Mines	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$139.99 -2.0%	C$105.00	Buy
AEO American Eagle Outfitters	Reiterated by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Dana Telsey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$12.33 +1.8%	$18.00 ➝ $18.00	Market Perform ➝ Market Perform
AEO American Eagle Outfitters	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Paul Lejuez Subscribe to MarketBeat All Access for the recommendation accuracy rating	$12.33 +1.8%	$21.00 ➝ $13.00	Neutral ➝ Neutral
ALHC Alignment Healthcare	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lisa Gill Subscribe to MarketBeat All Access for the recommendation accuracy rating	$15.25 -3.5%	$14.00 ➝ $17.00	Neutral ➝ Neutral
ALTO Alto Ingredients	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Amit Dayal Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.57 +6.8%	$5.50 ➝ $5.50	Buy ➝ Buy
ALXO ALX Oncology	Upgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Yee Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.31 +26.0%	$2.00 ➝ $3.00	Hold ➝ Buy
ALXO ALX Oncology	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Christopher Raymond Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.31 +26.0%	$8.00 ➝ $9.00	Overweight ➝ Overweight
ANF Abercrombie & Fitch	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Paul Lejuez Subscribe to MarketBeat All Access for the recommendation accuracy rating	$83.67 -4.1%	$160.00 ➝ $135.00	Buy ➝ Buy
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
ANF Abercrombie & Fitch	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Serna Subscribe to MarketBeat All Access for the recommendation accuracy rating	$83.67 -4.1%	$210.00 ➝ $150.00	Buy ➝ Buy
ANF Abercrombie & Fitch	Target Lowered by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Dana Telsey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$83.67 -4.1%	$190.00 ➝ $125.00	Outperform ➝ Outperform
ANTO Antofagasta	Reiterated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 1,863.50 +2.4%	GBX 2,400	Overweight
APR.UN Automotive Properties Real Est Invt TR	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$10.00 -2.8%	C$13.50 ➝ C$13.00	Buy
ARBE Arbe Robotics	Downgraded by	Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Matthew Galinko Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.30 -3.7%		Buy ➝ Hold
ATG Auction Technology Group	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 567 -0.5%	GBX 780 ➝ GBX 790	Overweight
ATH Athabasca Oil	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$4.58 +5.0%	C$7.00 ➝ C$6.00
AV Aviva	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 541.80 +1.5%	GBX 615 ➝ GBX 635	Overweight
AXSM Axsome Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Raghuram Selvaraju Subscribe to MarketBeat All Access for the recommendation accuracy rating	$124.41 -0.6%	$200.00 ➝ $200.00	Buy ➝ Buy
BALY Bally's	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jeffrey Stantial Subscribe to MarketBeat All Access for the recommendation accuracy rating	$12.62 -2.9%	$17.00 ➝ $14.00	Hold ➝ Hold
BARC Barclays	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 308.49 +1.7%	GBX 320 ➝ GBX 350	Buy
BLFS BioLife Solutions	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Y. Chen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$26.80 +2.1%	$27.00 ➝ $30.00	Buy ➝ Buy
BREE Breedon Group	Target Raised by	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 478 -0.1%	GBX 540 ➝ GBX 590	Buy
BRLT Brilliant Earth Group	Reiterated by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Telsey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.38 +3.0%	$2.00 ➝ $2.00	Market Perform ➝ Market Perform
BSM Black Stone Minerals	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mark Lear Subscribe to MarketBeat All Access for the recommendation accuracy rating	$14.67 +0.3%	$14.00 ➝ $16.00	Neutral ➝ Neutral
BURL Burlington Stores	Reiterated by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Dana Telsey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$256.63 +8.3%	$340.00 ➝ $340.00	Outperform ➝ Outperform
BWEN Broadwind	Target Lowered by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Amit Dayal Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.56	$8.00 ➝ $6.00	Buy ➝ Buy
CAG Conagra Brands	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ken Goldman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$25.96 +2.3%	$29.00 ➝ $26.00	Neutral ➝ Neutral
CALM Cal-Maine Foods	Reiterated by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	P. Sharma Subscribe to MarketBeat All Access for the recommendation accuracy rating	$82.65 -1.8%	$97.00 ➝ $97.00	Equal Weight ➝ Equal Weight
CART Maplebear	Target Lowered by	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Rob Sanderson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$37.75 -2.2%	$56.00 ➝ $52.00	Buy ➝ Buy
CCEP Coca-Cola Europacific Partners	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lauren Lieberman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$84.45 -0.3%	$92.00 ➝ $98.00	Overweight ➝ Overweight
CE Celanese	Upgraded by	Vertical Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	K. Mccarthy Subscribe to MarketBeat All Access for the recommendation accuracy rating	$55.25 +1.7%	$66.00	Sell ➝ Hold
CHRD Chord Energy	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mark Lear Subscribe to MarketBeat All Access for the recommendation accuracy rating	$102.45 +1.1%	$193.00 ➝ $184.00	Overweight ➝ Overweight
CING Cingulate	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Raghuram Selvaraju Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.83 +1.9%	$20.00 ➝ $20.00	Buy ➝ Buy
CLMB Climb Global Solutions	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Vincent Colicchio Subscribe to MarketBeat All Access for the recommendation accuracy rating	$133.99 +12.8%	$136.00 ➝ $136.00	Outperform ➝ Outperform
CLSD Clearside Biomedical	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Serge Belanger Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.98 +14.8%	$6.00 ➝ $6.00	Buy ➝ Buy
CLSD Clearside Biomedical	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Yi Chen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.98 +14.8%	$6.00 ➝ $6.00	Buy ➝ Buy
CMPO CompoSecure	Target Lowered by	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jacob Stephan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$11.56 -3.8%	$18.00 ➝ $15.00	Buy ➝ Buy
CMPO CompoSecure	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	John Todaro Subscribe to MarketBeat All Access for the recommendation accuracy rating	$11.56 -3.8%	$16.00 ➝ $15.00	Buy ➝ Buy
CMPO CompoSecure	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reginald Smith Subscribe to MarketBeat All Access for the recommendation accuracy rating	$11.56 -3.8%	$16.00 ➝ $15.00	Neutral ➝ Neutral
The real reason gold is soaring (and likely to continue) (Ad) Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driving a hidden gold market boom. Garrett Goggin, a renowned precious metals expert with 20+ years of experience, reveals 5 explosive investment opportunities set to explode in this new era. Backed by triple-digit returns in 2024, Garrett’s insights show you how to position yourself for wealth in 2025. Don’t wait—these opportunities can disappear fast! Discover Garrett’s highly sought-after gold insights and seize this opportunity before it’s gone.
COA Coats Group	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 85.90 -0.9%	GBX 135	Buy
CPB Campbell Soup	Downgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ken Goldman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$39.79 +1.6%	$48.00 ➝ $37.00	Overweight ➝ Neutral
CPB Campbell Soup	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Peter Galbo Subscribe to MarketBeat All Access for the recommendation accuracy rating	$39.79 +1.6%	$45.00 ➝ $41.00	Underperform ➝ Underperform
CPB Campbell Soup	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Chris Carey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$39.79 +1.6%	$43.00 ➝ $40.00	Equal Weight ➝ Equal Weight
CPB Campbell Soup	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Nik Modi Subscribe to MarketBeat All Access for the recommendation accuracy rating	$39.79 +1.6%	$51.00 ➝ $44.00	Sector Perform ➝ Sector Perform
CPB Campbell Soup	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Thomas Palmer Subscribe to MarketBeat All Access for the recommendation accuracy rating	$39.79 +1.6%	$39.00 ➝ $37.00	Sell ➝ Sell
CRCT Cricut	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Erik Woodring Subscribe to MarketBeat All Access for the recommendation accuracy rating	$5.68 +4.4%	$3.90 ➝ $3.80	Underweight ➝ Underweight
CSCO Cisco Systems	Reiterated by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$63.41 -0.9%		Equal Weight ➝ Equal Weight
CSCO Cisco Systems	Reiterated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$63.41 -0.9%		Equal Weight ➝ Equal Weight
CSCO Cisco Systems	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Malik Subscribe to MarketBeat All Access for the recommendation accuracy rating	$63.41 -0.9%		Overweight ➝ Overweight
CSCO Cisco Systems	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$63.41 -0.9%		Neutral ➝ Neutral
CTOS Custom Truck One Source	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Scott Schneeberger Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4.97 +2.8%	$5.00 ➝ $6.00	Outperform ➝ Outperform
CTRA Coterra Energy	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mark Lear Subscribe to MarketBeat All Access for the recommendation accuracy rating	$25.50 -2.3%	$34.00 ➝ $37.00	Overweight ➝ Overweight
CUBE CubeSmart	Upgraded by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Todd Thomas Subscribe to MarketBeat All Access for the recommendation accuracy rating	$42.24 -0.5%	$47.00	Sector Weight ➝ Overweight
CXDO Crexendo	Target Raised by	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jesse Sobelson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$6.75 -5.7%	$7.00 ➝ $10.00	Buy ➝ Buy
CZR Caesars Entertainment	Upgraded by	Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joseph Stauff Subscribe to MarketBeat All Access for the recommendation accuracy rating	$28.91 -4.8%	$30.00 ➝ $30.00	Negative ➝ Neutral
DG Dollar General	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Lasser Subscribe to MarketBeat All Access for the recommendation accuracy rating	$76.13 +3.3%	$108.00 ➝ $95.00	Buy ➝ Buy
DG Dollar General	Target Lowered by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joseph Feldman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$76.13 +3.3%	$88.00 ➝ $85.00	Market Perform ➝ Market Perform
DIN Dine Brands Global	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating	$25.39 +4.6%	$32.00 ➝ $26.00	Equal Weight ➝ Equal Weight
DIN Dine Brands Global	Target Lowered by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	N. Setyan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$25.39 +4.6%	$28.00 ➝ $26.00	Neutral ➝ Neutral
DIN Dine Brands Global	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Geiger Subscribe to MarketBeat All Access for the recommendation accuracy rating	$25.39 +4.6%	$32.00 ➝ $25.00	Neutral ➝ Neutral
DIN Dine Brands Global	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jake Bartlett Subscribe to MarketBeat All Access for the recommendation accuracy rating	$25.39 +4.6%	$37.00 ➝ $27.00	Hold ➝ Hold
DKS DICK'S Sporting Goods	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Seth Basham Subscribe to MarketBeat All Access for the recommendation accuracy rating	$214.86 -0.8%	$215.00 ➝ $215.00	Neutral ➝ Neutral
DLTR Dollar Tree	Reiterated by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Feldman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$69.10 -1.5%	$75.00 ➝ $75.00	Market Perform ➝ Market Perform
DSGX The Descartes Systems Group	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Paul Treiber Subscribe to MarketBeat All Access for the recommendation accuracy rating	$101.71 -8.3%	$133.00 ➝ $130.00	Outperform ➝ Outperform
DSGX The Descartes Systems Group	Target Lowered by	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$101.71 -8.3%	$128.00 ➝ $127.00	Outperform
DSGX The Descartes Systems Group	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Thanos Moschopoulos Subscribe to MarketBeat All Access for the recommendation accuracy rating	$101.71 -8.3%	$120.00 ➝ $113.00	Market Perform ➝ Market Perform
DSGX The Descartes Systems Group	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Lenschow Subscribe to MarketBeat All Access for the recommendation accuracy rating	$101.71 -8.3%	$125.00 ➝ $118.00	Equal Weight ➝ Equal Weight
DSGX The Descartes Systems Group	Target Lowered by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Campbell Subscribe to MarketBeat All Access for the recommendation accuracy rating	$101.71 -8.3%	$145.00 ➝ $137.00	Overweight ➝ Overweight
EDV Endeavour Mining	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 1,670 +4.9%	GBX 2,100	Buy
ELAN Elanco Animal Health	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Westenberg Subscribe to MarketBeat All Access for the recommendation accuracy rating	$10.82 -0.2%	$16.00 ➝ $12.00	Neutral ➝ Neutral
ENLT Enlight Renewable Energy	Initiated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$16.60 -0.1%	$22.00	Buy
EOG EOG Resources	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Lear Subscribe to MarketBeat All Access for the recommendation accuracy rating	$122.16 +0.3%	$141.00 ➝ $135.00	Neutral ➝ Neutral
EPD Enterprise Products Partners	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Richardson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$32.83 -0.8%	$33.00 ➝ $35.00	Sector Perform ➝ Sector Perform
EPR EPR Properties	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Carroll Subscribe to MarketBeat All Access for the recommendation accuracy rating	$52.76 -1.2%	$50.00 ➝ $58.00	Outperform ➝ Outperform
EQT EQT	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mark Lear Subscribe to MarketBeat All Access for the recommendation accuracy rating	$46.15 -7.9%	$35.00 ➝ $36.00	Neutral ➝ Neutral
ESTA Establishment Labs	Reiterated by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Carrico Subscribe to MarketBeat All Access for the recommendation accuracy rating	$42.08 -3.5%	$52.00 ➝ $52.00	Overweight ➝ Overweight
ET Evertz Technologies	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$11.18 -2.5%	C$15.00 ➝ C$13.50
ET Evertz Technologies	Target Lowered by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$11.18 -2.5%	C$16.00 ➝ C$14.00	Outperform
ETN Eaton	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Deane Dray Subscribe to MarketBeat All Access for the recommendation accuracy rating	$277.03 -3.7%	$405.00 ➝ $376.00	Outperform ➝ Outperform
EVGO EVgo	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Stephen Gengaro Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.51 -2.0%	$10.00 ➝ $8.00	Buy ➝ Buy
EXE Chesapeake Energy	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Lear Subscribe to MarketBeat All Access for the recommendation accuracy rating	$96.24 -5.3%	$96.00 ➝ $101.00	Neutral ➝ Neutral
EYPT EyePoint Pharmaceuticals	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Yi Chen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$6.82 +3.6%	$22.00 ➝ $22.00	Buy ➝ Buy
EYPT EyePoint Pharmaceuticals	Reiterated by	Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Daniil Gataulin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$6.82 +3.6%	$33.00 ➝ $33.00	Buy ➝ Buy
FATE Fate Therapeutics	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Benjamin Burnett Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.04 +14.9%	$5.00 ➝ $3.00	Hold ➝ Hold
FATE Fate Therapeutics	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Gil Blum Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.04 +14.9%		Hold ➝ Hold
FATE Fate Therapeutics	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Nierengarten Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.04 +14.9%	$5.00 ➝ $5.00	Neutral ➝ Neutral
FATE Fate Therapeutics	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Yanan Zhu Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.04 +14.9%	$5.00 ➝ $4.00	Equal Weight ➝ Equal Weight
FCX Freeport-McMoRan	Upgraded by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Abhi Agarwal Subscribe to MarketBeat All Access for the recommendation accuracy rating	$37.66 -1.3%	$47.00 ➝ $47.00	Hold ➝ Buy
FDX FedEx	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Christian Wetherbee Subscribe to MarketBeat All Access for the recommendation accuracy rating	$249.67 -0.3%	$320.00 ➝ $275.00	Equal Weight ➝ Equal Weight
The real reason gold is soaring (and likely to continue) (Ad) Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driving a hidden gold market boom. Garrett Goggin, a renowned precious metals expert with 20+ years of experience, reveals 5 explosive investment opportunities set to explode in this new era. Backed by triple-digit returns in 2024, Garrett’s insights show you how to position yourself for wealth in 2025. Don’t wait—these opportunities can disappear fast! Discover Garrett’s highly sought-after gold insights and seize this opportunity before it’s gone.
FL Foot Locker	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jay Sole Subscribe to MarketBeat All Access for the recommendation accuracy rating	$17.82 -2.4%	$22.00 ➝ $21.00	Neutral ➝ Neutral
FL Foot Locker	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jonathan Komp Subscribe to MarketBeat All Access for the recommendation accuracy rating	$17.82 -2.4%	$24.00 ➝ $20.00	Neutral ➝ Neutral
FL Foot Locker	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Anna Andreeva Subscribe to MarketBeat All Access for the recommendation accuracy rating	$17.82 -2.4%	$23.00 ➝ $19.00	Neutral ➝ Neutral
FLUT Flutter Entertainment	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Shelley Subscribe to MarketBeat All Access for the recommendation accuracy rating	$256.96 -4.8%	$335.00 ➝ $340.00	Buy ➝ Buy
FN First National Financial	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$40.59 +0.7%	C$41.00 ➝ C$42.00
FN First National Financial	Target Lowered by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$40.59 +0.7%	C$46.00 ➝ C$45.00	Buy
FN First National Financial	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$40.59 +0.7%	C$44.00 ➝ C$45.00	Sector Perform
FTEK Fuel Tech	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Amit Dayal Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.01 -1.5%	$4.00 ➝ $4.00	Buy ➝ Buy
FWONK Formula One Group	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Karnovsky Subscribe to MarketBeat All Access for the recommendation accuracy rating	$92.52 -0.9%	$96.00 ➝ $105.00	Overweight ➝ Overweight
GDI GDI Integrated Facility Services	Target Lowered by	Desjardins Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$33.31 -1.3%	C$50.00 ➝ C$48.00	Buy
GH Guardant Health	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Shannon O'Callaghan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$40.17 -5.8%	$42.00 ➝ $52.00	Overweight ➝ Overweight
H Hyatt Hotels	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	L. Dove Subscribe to MarketBeat All Access for the recommendation accuracy rating	$136.82 -2.2%	$170.00 ➝ $150.00	Neutral ➝ Neutral
HALO Halozyme Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mitchell Kapoor Subscribe to MarketBeat All Access for the recommendation accuracy rating	$60.15 +1.0%		Buy ➝ Buy
HCAT Health Catalyst	Target Lowered by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jeff Garro Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4.43 -2.6%	$7.00 ➝ $5.00	Equal Weight ➝ Equal Weight
HFG Hilton Food Group	Reiterated by	Shore Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 847 +1.1%		House Stock
HIMS Hims & Hers Health	Reiterated by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Allen Lutz Subscribe to MarketBeat All Access for the recommendation accuracy rating	$34.32 -16.1%	$21.00 ➝ $21.00	Underperform ➝ Underperform
HIMS Hims & Hers Health	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Grosslight Subscribe to MarketBeat All Access for the recommendation accuracy rating	$34.32 -16.1%	$27.00 ➝ $27.00	Sell ➝ Sell
HLLY Holley	Reiterated by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joseph Feldman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.47 +0.2%	$4.50 ➝ $4.50	Outperform ➝ Outperform
HOOD Robinhood Markets	Initiated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$44.84 -6.8%	$69.00	Overweight
HSBA HSBC	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 881 -5.1%	GBX 960 ➝ GBX 1,070	Buy
HTG Hunting	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 289.67 -5.6%	GBX 600	Buy
HTG Hunting	Target Raised by	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 289.67 -5.6%	GBX 480 ➝ GBX 490	Buy
IBRX ImmunityBio	Initiated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Fein Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.99 -2.3%	$8.00	Buy
ICG Intermediate Capital Group	Reiterated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 2,178 -1.4%		Overweight
IGC IGC Pharma	Reiterated by	Alliance Global Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	James Molloy Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.31 -6.5%	$3.50 ➝ $3.50	Buy ➝ Buy
INCH Inchcape	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 728 +1.0%	GBX 1,113 ➝ GBX 1,194	Buy
INDV Indivior	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Amsellem Subscribe to MarketBeat All Access for the recommendation accuracy rating	$9.89 -1.2%	$16.00 ➝ $13.00	Overweight ➝ Overweight
INSM Insmed	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Trung Huynh Subscribe to MarketBeat All Access for the recommendation accuracy rating	$75.02 -3.3%	$105.00 ➝ $110.00	Buy ➝ Buy
INVE Identiv	Target Lowered by	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jaeson Schmidt Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.24 -6.6%	$7.00 ➝ $6.00	Buy ➝ Buy
ITOS iTeos Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the recommendation accuracy rating	$7.09 -2.3%	$46.00 ➝ $46.00	Buy ➝ Buy
ITOS iTeos Therapeutics	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brian Cheng Subscribe to MarketBeat All Access for the recommendation accuracy rating	$7.09 -2.3%	$22.00 ➝ $15.00	Overweight ➝ Overweight
ITOS iTeos Therapeutics	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Eva Fortea Verdejo Subscribe to MarketBeat All Access for the recommendation accuracy rating	$7.09 -2.3%	$19.00 ➝ $17.00	Overweight ➝ Overweight
JAZZ Jazz Pharmaceuticals	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Gregory Fraser Subscribe to MarketBeat All Access for the recommendation accuracy rating	$136.45 -2.7%	$220.00 ➝ $230.00	Buy ➝ Buy
KMDA Kamada	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Fein Subscribe to MarketBeat All Access for the recommendation accuracy rating	$7.32 +3.1%	$11.00 ➝ $11.00	Buy ➝ Buy
KMR Kenmare Resources	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 390 +41.8%	GBX 350	Hold
KNTK Kinetik	Target Lowered by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Richardson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$51.31 -4.8%	$62.00 ➝ $60.00	Sector Outperform ➝ Sector Outperform
KNTK Kinetik	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Theresa Chen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$51.31 -4.8%	$61.00 ➝ $57.00	Equal Weight ➝ Equal Weight
KPT KP Tissue	Target Lowered by	Desjardins Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$8.09 +0.7%	C$10.00 ➝ C$8.50	Hold
KURA Kura Oncology	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Dai Subscribe to MarketBeat All Access for the recommendation accuracy rating	$7.70 +4.5%	$27.00 ➝ $14.00	Buy ➝ Buy
LINE Lineage	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Carroll Subscribe to MarketBeat All Access for the recommendation accuracy rating	$61.00 -1.2%	$81.00 ➝ $74.00	Outperform ➝ Outperform
LLOY Lloyds Banking Group	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 72.74 -0.5%	GBX 61 ➝ GBX 71	Buy
LNG Cheniere Energy	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Richardson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$215.30 -1.0%	$247.00 ➝ $254.00	Sector Outperform ➝ Sector Outperform
LNR Linamar	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$51.65 +1.8%	C$75.00 ➝ C$65.00
LNR Linamar	Target Lowered by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Morrison Subscribe to MarketBeat All Access for the recommendation accuracy rating	C$51.65 +1.8%	C$66.00 ➝ C$60.00	Hold
LPSN LivePerson	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ryan MacDonald Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.92 -16.0%		Hold ➝ Hold
LUN Lundin Mining	Target Set by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$12.45 +3.0%	C$16.60	Buy
LYV Live Nation Entertainment	Target Raised by	Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating	Paul Golding Subscribe to MarketBeat All Access for the recommendation accuracy rating	$130.90 -4.3%	$146.00 ➝ $165.00	Outperform ➝ Outperform
M Macy's	Downgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$13.21 -0.8%	$19.00 ➝ $14.00	Overweight ➝ Neutral
M Macy's	Downgraded by	Gordon Haskett Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Grom Subscribe to MarketBeat All Access for the recommendation accuracy rating	$13.21 -0.8%		Accumulate ➝ Hold
M Macy's	Reiterated by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Dana Telsey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$13.21 -0.8%	$17.00 ➝ $17.00	Market Perform ➝ Market Perform
“Amazon Coin” set to outperform Bitcoin (Ad) Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... But today, Chris is now making the biggest crypto call of his ENTIRE career… #1 FREE Crypto for 2025
MAC Macerich	Target Lowered by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	G. Mcginniss Subscribe to MarketBeat All Access for the recommendation accuracy rating	$17.58 -3.3%	$22.00 ➝ $21.00	Sector Perform ➝ Sector Perform
MDB MongoDB	Downgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Nowinski Subscribe to MarketBeat All Access for the recommendation accuracy rating	$192.98 -26.9%	$365.00 ➝ $225.00	Overweight ➝ Equal Weight
MDB MongoDB	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	William Power Subscribe to MarketBeat All Access for the recommendation accuracy rating	$192.98 -26.9%	$390.00 ➝ $300.00	Outperform ➝ Outperform
MDB MongoDB	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mike Cikos Subscribe to MarketBeat All Access for the recommendation accuracy rating	$192.98 -26.9%	$415.00 ➝ $270.00	Buy ➝ Buy
MDB MongoDB	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Hynes Subscribe to MarketBeat All Access for the recommendation accuracy rating	$192.98 -26.9%	$385.00 ➝ $320.00	Buy ➝ Buy
MDB MongoDB	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Bradley Sills Subscribe to MarketBeat All Access for the recommendation accuracy rating	$192.98 -26.9%	$420.00 ➝ $286.00	Buy ➝ Buy
MDB MongoDB	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Sanjit Singh Subscribe to MarketBeat All Access for the recommendation accuracy rating	$192.98 -26.9%	$350.00 ➝ $315.00	Overweight ➝ Overweight
MDB MongoDB	Target Lowered by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Ives Subscribe to MarketBeat All Access for the recommendation accuracy rating	$192.98 -26.9%	$360.00 ➝ $300.00	Outperform ➝ Outperform
MDB MongoDB	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Kash Rangan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$192.98 -26.9%	$390.00 ➝ $335.00	Buy ➝ Buy
MDB MongoDB	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brad Reback Subscribe to MarketBeat All Access for the recommendation accuracy rating	$192.98 -26.9%	$425.00 ➝ $340.00	Buy ➝ Buy
MDB MongoDB	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Miller Jump Subscribe to MarketBeat All Access for the recommendation accuracy rating	$192.98 -26.9%	$400.00 ➝ $300.00	Buy ➝ Buy
MDB MongoDB	Target Lowered by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ittai Kidron Subscribe to MarketBeat All Access for the recommendation accuracy rating	$192.98 -26.9%	$400.00 ➝ $330.00	Outperform ➝ Outperform
MDB MongoDB	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brent Bracelin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$192.98 -26.9%	$425.00 ➝ $280.00	Overweight ➝ Overweight
MDB MongoDB	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Raimo Lenschow Subscribe to MarketBeat All Access for the recommendation accuracy rating	$192.98 -26.9%	$330.00 ➝ $280.00	Overweight ➝ Overweight
MDB MongoDB	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Rishi Jaluria Subscribe to MarketBeat All Access for the recommendation accuracy rating	$192.98 -26.9%	$400.00 ➝ $320.00	Outperform ➝ Outperform
MEC Mayville Engineering	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Kaplowitz Subscribe to MarketBeat All Access for the recommendation accuracy rating	$14.20 +3.1%	$22.00 ➝ $18.00	Buy ➝ Buy
MI.UN Minto Apartment Real Estate Invt Trust	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$13.01 -4.1%	C$15.50 ➝ C$15.00
MMM 3M	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Obin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$146.98 -0.4%	$175.00 ➝ $179.00	Buy ➝ Buy
MRVL Marvell Technology	Upgraded by	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	G. Mobley Subscribe to MarketBeat All Access for the recommendation accuracy rating	$72.28 -19.8%	$110.00	Hold ➝ Buy
MRVL Marvell Technology	Downgraded by	Summit Insights Subscribe to MarketBeat All Access for the recommendation accuracy rating		$72.28 -19.8%		Buy ➝ Hold
MRVL Marvell Technology	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Buchalter Subscribe to MarketBeat All Access for the recommendation accuracy rating	$72.28 -19.8%	$125.00 ➝ $95.00	Buy
MRVL Marvell Technology	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Cody Acree Subscribe to MarketBeat All Access for the recommendation accuracy rating	$72.28 -19.8%	$135.00 ➝ $135.00	Buy ➝ Buy
MRVL Marvell Technology	Reiterated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Kevin Cassidy Subscribe to MarketBeat All Access for the recommendation accuracy rating	$72.28 -19.8%	$140.00 ➝ $140.00	Buy ➝ Buy
MRVL Marvell Technology	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Quinn Bolton Subscribe to MarketBeat All Access for the recommendation accuracy rating	$72.28 -19.8%	$120.00 ➝ $100.00	Buy ➝ Buy
MRVL Marvell Technology	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Vivek Arya Subscribe to MarketBeat All Access for the recommendation accuracy rating	$72.28 -19.8%	$150.00 ➝ $120.00	Buy ➝ Buy
MRVL Marvell Technology	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joseph Moore Subscribe to MarketBeat All Access for the recommendation accuracy rating	$72.28 -19.8%	$113.00 ➝ $90.00	Equal Weight ➝ Equal Weight
MRVL Marvell Technology	Target Lowered by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	John Vinh Subscribe to MarketBeat All Access for the recommendation accuracy rating	$72.28 -19.8%	$135.00 ➝ $115.00	Overweight ➝ Overweight
MRVL Marvell Technology	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Thomas O'Malley Subscribe to MarketBeat All Access for the recommendation accuracy rating	$72.28 -19.8%	$150.00 ➝ $130.00	Overweight ➝ Overweight
MRVL Marvell Technology	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Atif Malik Subscribe to MarketBeat All Access for the recommendation accuracy rating	$72.28 -19.8%	$136.00 ➝ $122.00	Buy ➝ Buy
MRVL Marvell Technology	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Harsh Kumar Subscribe to MarketBeat All Access for the recommendation accuracy rating	$72.28 -19.8%	$120.00 ➝ $95.00	Overweight ➝ Overweight
MRVL Marvell Technology	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tore Svanberg Subscribe to MarketBeat All Access for the recommendation accuracy rating	$72.28 -19.8%	$130.00 ➝ $115.00	Buy ➝ Buy
MUR Murphy Oil	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mark Lear Subscribe to MarketBeat All Access for the recommendation accuracy rating	$24.10 +0.3%	$35.00 ➝ $34.00	Overweight ➝ Overweight
NCLH Norwegian Cruise Line	Target Raised by	Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating	Paul Golding Subscribe to MarketBeat All Access for the recommendation accuracy rating	$19.96 -6.3%	$30.00 ➝ $31.00	Outperform ➝ Outperform
NEXN Nexxen International	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Laura Martin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$9.02 -5.1%	$12.00 ➝ $12.00	Buy ➝ Buy
NFI NFI Group	Target Raised by	ATB Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$11.49 +2.2%	C$22.00 ➝ C$24.00	Outperform
NLOP Net Lease Office Properties	Reiterated by	BWS Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Hamed Khorsand Subscribe to MarketBeat All Access for the recommendation accuracy rating	$31.35 -2.2%	$46.00 ➝ $46.00	Buy ➝ Buy
NRR NewRiver REIT	Reiterated by	Shore Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 66.30 -2.1%		House Stock
NTRS Northern Trust	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Betsy Graseck Subscribe to MarketBeat All Access for the recommendation accuracy rating	$103.83 -1.5%	$138.00 ➝ $136.00	Equal Weight ➝ Equal Weight
NVST Envista	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Saxon Subscribe to MarketBeat All Access for the recommendation accuracy rating	$17.84 -2.2%		Hold ➝ Hold
NVST Envista	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Erin Wright Subscribe to MarketBeat All Access for the recommendation accuracy rating	$17.84 -2.2%	$20.00 ➝ $19.00	Equal Weight ➝ Equal Weight
NVST Envista	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Rachel Vatnsdal Subscribe to MarketBeat All Access for the recommendation accuracy rating	$17.84 -2.2%	$20.00 ➝ $19.00	Neutral ➝ Neutral
NWG NatWest Group	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 464.30 -1.5%	GBX 580 ➝ GBX 615	Buy
NXE NexGen Energy	Target Lowered by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$7.08 -0.6%	C$13.00 ➝ C$12.00	Buy
NXE NexGen Energy	Target Lowered by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$7.08 -0.6%	C$14.50 ➝ C$12.00	Outperform
NYAX Nayax	Target Raised by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating	Sanjay Sakhrani Subscribe to MarketBeat All Access for the recommendation accuracy rating	$34.65 -2.2%	$33.00 ➝ $38.00	Market Perform ➝ Market Perform
OCGN Ocugen	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.63 +10.0%	$8.00 ➝ $8.00	Buy ➝ Buy
OCGN Ocugen	Target Raised by	Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Daniil Gataulin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.63 +10.0%	$6.00 ➝ $7.00	Buy ➝ Buy
OKE ONEOK	Target Lowered by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Richardson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$89.69 -2.4%	$109.00 ➝ $102.00	Sector Outperform ➝ Sector Outperform
OPCH Option Care Health	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lisa Gill Subscribe to MarketBeat All Access for the recommendation accuracy rating	$34.26 -1.0%	$40.00 ➝ $41.00	Overweight ➝ Overweight
OXY Occidental Petroleum	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mark Lear Subscribe to MarketBeat All Access for the recommendation accuracy rating	$45.69 +0.4%	$51.00 ➝ $50.00	Neutral ➝ Neutral
“Amazon Coin” set to outperform Bitcoin (Ad) Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... But today, Chris is now making the biggest crypto call of his ENTIRE career… #1 FREE Crypto for 2025
PAA Plains All American Pipeline	Target Lowered by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Richardson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$19.00 +0.3%	$23.00 ➝ $22.00	Sector Outperform ➝ Sector Outperform
PEP PepsiCo	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lauren Lieberman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$154.61 +0.5%	$153.00 ➝ $168.00	Overweight ➝ Overweight
PHAT Phathom Pharmaceuticals	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joseph Stringer Subscribe to MarketBeat All Access for the recommendation accuracy rating	$5.90 -3.0%	$28.00 ➝ $28.00	Buy ➝ Buy
PLUG Plug Power	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Arthur Sitbon Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.65 -2.4%	$1.75 ➝ $1.60	Underweight ➝ Underweight
PODD Insulet	Initiated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Shagun Singh Subscribe to MarketBeat All Access for the recommendation accuracy rating	$259.67 -4.1%	$340.00	Outperform
PR Permian Resources	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mark Lear Subscribe to MarketBeat All Access for the recommendation accuracy rating	$12.45 +0.1%	$21.00 ➝ $20.00	Overweight ➝ Overweight
PRKS United Parks & Resorts	Target Lowered by	Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating	Paul Golding Subscribe to MarketBeat All Access for the recommendation accuracy rating	$49.37 -0.6%	$70.00 ➝ $65.00	Outperform ➝ Outperform
PRTS CarParts.com	Upgraded by	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.19 -4.0%	$3.00	Hold ➝ Buy
PXT Parex Resources	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$12.63 +2.7%	C$15.00 ➝ C$16.00	Sector Perform
RDFN Redfin	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tom Champion Subscribe to MarketBeat All Access for the recommendation accuracy rating	$5.86 -8.4%	$7.00 ➝ $4.00	Underweight ➝ Underweight
RGTI Rigetti Computing	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Quinn Bolton Subscribe to MarketBeat All Access for the recommendation accuracy rating	$8.51 +4.0%	$17.00 ➝ $17.00	Buy ➝ Buy
RGTI Rigetti Computing	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Williams Subscribe to MarketBeat All Access for the recommendation accuracy rating	$8.51 +4.0%	$14.00 ➝ $14.00	Buy ➝ Buy
RIGL Rigel Pharmaceuticals	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Yigal Nochomovitz Subscribe to MarketBeat All Access for the recommendation accuracy rating	$19.70 -2.9%	$49.00 ➝ $55.00	Buy ➝ Buy
RR Rolls-Royce Holdings plc	Reiterated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 805.20 +2.4%	GBX 900	Overweight
RRC Range Resources	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mark Lear Subscribe to MarketBeat All Access for the recommendation accuracy rating	$35.39 -5.7%	$32.00 ➝ $33.00	Neutral ➝ Neutral
RSKD Riskified	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Will Nance Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4.94 -5.3%	$4.00 ➝ $4.50	Sell ➝ Sell
RSKD Riskified	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Clarke Jeffries Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4.94 -5.3%	$6.00 ➝ $7.00	Overweight ➝ Overweight
SCR Strathcona Resources	Target Lowered by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$26.27 +6.5%	C$32.00 ➝ C$29.00	Hold
SCR Strathcona Resources	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$26.27 +6.5%	C$35.00 ➝ C$34.00	Sector Perform
SGHT Sight Sciences	Target Lowered by	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	F. Takkinen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.49 +2.9%	$3.00 ➝ $2.50	Hold ➝ Hold
SGHT Sight Sciences	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Saxon Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.49 +2.9%		Hold ➝ Hold
SGHT Sight Sciences	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Matt O'Brien Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.49 +2.9%	$5.50 ➝ $3.50	Neutral ➝ Neutral
SGHT Sight Sciences	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Thomas Stephan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.49 +2.9%	$5.00 ➝ $4.00	Buy ➝ Buy
SHI SIG	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 13.12 +7.9%	GBX 17 ➝ GBX 14	Buy
SMRT SmartRent	Target Lowered by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ryan Tomasello Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.27 -7.0%	$2.00 ➝ $1.60	Market Perform ➝ Market Perform
SNBR Sleep Number	Target Lowered by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Seth Basham Subscribe to MarketBeat All Access for the recommendation accuracy rating	$7.49 -41.9%	$18.00 ➝ $12.00	Neutral ➝ Neutral
SNBR Sleep Number	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Peter Keith Subscribe to MarketBeat All Access for the recommendation accuracy rating	$7.49 -41.9%	$12.00 ➝ $11.00	Neutral ➝ Neutral
SSSS SuRo Capital	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Alexander Paris Subscribe to MarketBeat All Access for the recommendation accuracy rating	$5.31 -9.7%	$8.00 ➝ $8.00	Outperform ➝ Outperform
SSYS Stratasys	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	James Ricchiuti Subscribe to MarketBeat All Access for the recommendation accuracy rating	$9.74 -5.9%	$12.00 ➝ $13.00	Buy ➝ Buy
STAN Standard Chartered	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 1,241.27 -0.1%	GBX 1,170 ➝ GBX 1,250	Neutral
STT State Street	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Connor Lynagh Subscribe to MarketBeat All Access for the recommendation accuracy rating	$89.80 -3.0%	$142.00 ➝ $139.00	Overweight ➝ Overweight
SVCO Silvaco Group	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.91 -19.6%	$15.00 ➝ $12.00	Buy
SVCO Silvaco Group	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Charles Shi Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4.91 -19.6%	$19.00 ➝ $19.00	Buy ➝ Buy
SVCO Silvaco Group	Reiterated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Blair Abernethy Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4.91 -19.6%	$18.00 ➝ $18.00	Buy ➝ Buy
SVT Severn Trent	Reiterated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 2,370 -1.2%		Overweight
TARA Protara Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Fein Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.92 +8.0%	$23.00 ➝ $23.00	Buy ➝ Buy
TARS Tarsus Pharmaceuticals	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Anthony Petrone Subscribe to MarketBeat All Access for the recommendation accuracy rating	$43.57 -2.2%	$54.00 ➝ $58.00	Buy ➝ Buy
TCRX TScan Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Fein Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.08 +8.3%	$15.00 ➝ $15.00	Buy ➝ Buy
TCS Tecsys	Target Raised by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$40.97 -6.0%	C$45.00 ➝ C$50.00	Outperform
TD Toronto-Dominion Bank	Target Lowered by	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$84.73 -0.3%	C$96.00 ➝ C$95.00
TEM Tempus AI	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tejas Savant Subscribe to MarketBeat All Access for the recommendation accuracy rating	$48.86 -7.9%	$50.00 ➝ $60.00	Overweight ➝ Overweight
TEVA Teva Pharmaceutical Industries	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jason Gerberry Subscribe to MarketBeat All Access for the recommendation accuracy rating	$15.32 -3.6%	$23.00 ➝ $20.00	Buy ➝ Buy
TGT Target	Target Lowered by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Rupesh Parikh Subscribe to MarketBeat All Access for the recommendation accuracy rating	$113.78 -2.4%	$165.00 ➝ $150.00	Outperform ➝ Outperform
THO THOR Industries	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tristan Thomas-Martin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$86.56 +6.3%	$120.00 ➝ $105.00	Outperform ➝ Outperform
THO THOR Industries	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Craig Kennison Subscribe to MarketBeat All Access for the recommendation accuracy rating	$86.56 +6.3%	$110.00 ➝ $100.00	Outperform ➝ Outperform
THO THOR Industries	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Swartz Subscribe to MarketBeat All Access for the recommendation accuracy rating	$86.56 +6.3%	$110.00 ➝ $90.00	Hold ➝ Hold
TNL Travel + Leisure	Target Raised by	Tigress Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ivan Feinseth Subscribe to MarketBeat All Access for the recommendation accuracy rating	$53.50 -2.4%	$64.00 ➝ $70.00	Buy ➝ Buy
TPVG TriplePoint Venture Growth BDC	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Crispin Love Subscribe to MarketBeat All Access for the recommendation accuracy rating	$7.34 -5.3%	$7.50 ➝ $8.00	Neutral ➝ Neutral
TREE LendingTree	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mayank Tandon Subscribe to MarketBeat All Access for the recommendation accuracy rating	$49.34 +22.5%	$78.00 ➝ $65.00	Buy ➝ Buy
TREE LendingTree	Target Lowered by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ryan Tomasello Subscribe to MarketBeat All Access for the recommendation accuracy rating	$49.34 +22.5%	$73.00 ➝ $66.00	Outperform ➝ Outperform
TREE LendingTree	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Melissa Wedel Subscribe to MarketBeat All Access for the recommendation accuracy rating	$49.34 +22.5%	$65.00 ➝ $68.00	Overweight ➝ Overweight
TREE LendingTree	Reiterated by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	John Campbell Subscribe to MarketBeat All Access for the recommendation accuracy rating	$49.34 +22.5%	$69.00 ➝ $69.00	Overweight ➝ Overweight
TRGP Targa Resources	Target Lowered by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Richardson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$181.78 -2.7%	$218.00 ➝ $210.00	Sector Outperform ➝ Sector Outperform
TRML Tourmaline Bio	Initiated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Laura Chico Subscribe to MarketBeat All Access for the recommendation accuracy rating	$14.33 +11.1%	$42.00	Outperform
TSLA Tesla	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ben Kallo Subscribe to MarketBeat All Access for the recommendation accuracy rating	$263.45 -5.6%	$440.00 ➝ $370.00	Outperform ➝ Outperform
TXP Touchstone Exploration	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 21.90 -0.5%	GBX 60	Speculative Buy
TXP Touchstone Exploration	Reiterated by	Shore Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 21.90 -0.5%		House Stock
UBER Uber Technologies	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Youssef Squali Subscribe to MarketBeat All Access for the recommendation accuracy rating	$74.88 -2.1%	$90.00 ➝ $92.00	Buy ➝ Buy
UCTT Ultra Clean	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Charles Shi Subscribe to MarketBeat All Access for the recommendation accuracy rating	$23.89 -1.5%	$40.00 ➝ $40.00	Buy ➝ Buy
VBNK VersaBank	Target Lowered by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$15.05 +0.7%	C$27.00 ➝ C$22.00	Outperform
VBNK VersaBank	Downgraded by	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating		$10.67 +2.3%	$22.00 ➝ $10.40	Buy ➝ Neutral
VEEV Veeva Systems	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joe Vruwink Subscribe to MarketBeat All Access for the recommendation accuracy rating	$236.47 +7.5%	$283.00 ➝ $285.00	Outperform ➝ Outperform
VEEV Veeva Systems	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ryan MacDonald Subscribe to MarketBeat All Access for the recommendation accuracy rating	$236.47 +7.5%	$270.00 ➝ $270.00	Buy ➝ Buy
VEEV Veeva Systems	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Craig Hettenbach Subscribe to MarketBeat All Access for the recommendation accuracy rating	$236.47 +7.5%	$195.00 ➝ $201.00	Underweight ➝ Underweight
VEEV Veeva Systems	Reiterated by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Garro Subscribe to MarketBeat All Access for the recommendation accuracy rating	$236.47 +7.5%	$280.00 ➝ $280.00	Overweight ➝ Overweight
VEEV Veeva Systems	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Verkhovski Subscribe to MarketBeat All Access for the recommendation accuracy rating	$236.47 +7.5%	$240.00 ➝ $245.00	Sector Perform ➝ Sector Perform
VEEV Veeva Systems	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joe Meares Subscribe to MarketBeat All Access for the recommendation accuracy rating	$236.47 +7.5%	$210.00 ➝ $217.00	Hold ➝ Hold
VET Vermilion Energy	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Mccrea Subscribe to MarketBeat All Access for the recommendation accuracy rating	C$10.70 -1.8%	C$16.00 ➝ C$14.00
VSCO Victoria's Secret & Co.	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Simeon Siegel Subscribe to MarketBeat All Access for the recommendation accuracy rating	$20.34 -8.4%	$46.00 ➝ $31.00	Outperform ➝ Outperform
VSCO Victoria's Secret & Co.	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Matthew Boss Subscribe to MarketBeat All Access for the recommendation accuracy rating	$20.34 -8.4%	$43.00 ➝ $35.00	Neutral ➝ Neutral
VSCO Victoria's Secret & Co.	Target Lowered by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Dana Telsey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$20.34 -8.4%	$40.00 ➝ $24.00	Market Perform ➝ Market Perform
VSCO Victoria's Secret & Co.	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	I. Boruchow Subscribe to MarketBeat All Access for the recommendation accuracy rating	$20.34 -8.4%	$40.00 ➝ $25.00	Equal Weight ➝ Equal Weight
VTLE Vital Energy	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mark Lear Subscribe to MarketBeat All Access for the recommendation accuracy rating	$20.98 -3.9%	$32.00 ➝ $24.00	Neutral ➝ Neutral
VTMX Corporación Inmobiliaria Vesta	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Pablo Monsivais Subscribe to MarketBeat All Access for the recommendation accuracy rating	$24.60 +3.7%	$35.00 ➝ $34.00	Overweight ➝ Overweight
VYNE VYNE Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joseph Pantginis Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.33 -2.5%	$5.75 ➝ $5.75	Buy ➝ Buy
WAT Waters	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Rachel Vatnsdal Subscribe to MarketBeat All Access for the recommendation accuracy rating	$385.33 +1.7%	$380.00 ➝ $390.00	Neutral ➝ Neutral
WD Walker & Dunlop	Upgraded by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jade Rahmani Subscribe to MarketBeat All Access for the recommendation accuracy rating	$85.99 +2.2%	$105.00 ➝ $105.00	Market Perform ➝ Outperform
WELL Welltower	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Nicholas Yulico Subscribe to MarketBeat All Access for the recommendation accuracy rating	$148.93 -3.8%	$165.00 ➝ $166.00	Sector Outperform ➝ Sector Outperform
WEN Wendy's	Reiterated by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jim Salera Subscribe to MarketBeat All Access for the recommendation accuracy rating	$15.16 +1.4%	$15.00 ➝ $15.00	Equal Weight ➝ Equal Weight
WEST Westrock Coffee	Target Lowered by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Sarang Vora Subscribe to MarketBeat All Access for the recommendation accuracy rating	$6.71 -1.2%	$10.00 ➝ $9.00	Outperform ➝ Outperform
WMB Williams Companies	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Richardson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$54.64 -2.8%	$51.00 ➝ $53.00	Sector Perform ➝ Sector Perform
XPO XPO	Upgraded by	Vertical Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$110.89 -1.6%	$140.00	Hold ➝ Buy
XPS XPS Pensions Group	Reiterated by	Shore Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 371 -0.8%		Hold
XYZ Block	Reiterated by	Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating	Paul Golding Subscribe to MarketBeat All Access for the recommendation accuracy rating	$59.80 -2.2%	$110.00 ➝ $110.00	Outperform ➝ Outperform
YEXT Yext	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Macdonald Subscribe to MarketBeat All Access for the recommendation accuracy rating	$6.32 -3.7%	$10.00 ➝ $10.00	Buy ➝ Buy
YMM Full Truck Alliance	Upgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Karen Li Subscribe to MarketBeat All Access for the recommendation accuracy rating	$13.28 +0.1%	$13.00 ➝ $18.00	Neutral ➝ Overweight
ZS Zscaler	Upgraded by	Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Catharine Trebnick Subscribe to MarketBeat All Access for the recommendation accuracy rating	$202.16 +2.9%	$190.00 ➝ $235.00	Neutral ➝ Buy
ZS Zscaler	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brian Essex Subscribe to MarketBeat All Access for the recommendation accuracy rating	$202.16 +2.9%	$240.00 ➝ $250.00	Overweight ➝ Overweight
ZS Zscaler	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Shrenik Kothari Subscribe to MarketBeat All Access for the recommendation accuracy rating	$202.16 +2.9%	$240.00 ➝ $250.00	Outperform ➝ Outperform
ZS Zscaler	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Keith Bachman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$202.16 +2.9%	$222.00 ➝ $233.00	Outperform ➝ Outperform
ZS Zscaler	Target Raised by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Daniel Ives Subscribe to MarketBeat All Access for the recommendation accuracy rating	$202.16 +2.9%	$230.00 ➝ $240.00	Outperform ➝ Outperform
ZS Zscaler	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Nowinski Subscribe to MarketBeat All Access for the recommendation accuracy rating	$202.16 +2.9%	$190.00 ➝ $210.00	Equal Weight ➝ Equal Weight
ZS Zscaler	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Roger Boyd Subscribe to MarketBeat All Access for the recommendation accuracy rating	$202.16 +2.9%	$250.00 ➝ $260.00	Buy ➝ Buy
ZS Zscaler	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Matthew Hedberg Subscribe to MarketBeat All Access for the recommendation accuracy rating	$202.16 +2.9%	$230.00 ➝ $250.00	Outperform ➝ Outperform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 01:47 AM ET.

Stock Ratings and Recommendations: Understanding Analyst Ratings

Written by MarketBeat Staff

July 5, 2023

Key Points

Stock analysts give ratings to companies based on their research and insights.
Analysis comes from the buy side (fund companies, investment managers) or sell side (brokers, banks).
Analysts use different methodologies, so investors should always look into why a particular rating was given.
5 stocks we like better than EXA)

You'll often hear a particular stock called a "buy" or "sell," but who exactly makes these calls? Ratings and recommendations come from stock analysts, who research different securities and work for various institutions, brokerage firms and other financial companies.

Analyst ratings are designed to give additional information to investors beyond just what the company is saying, but are analyst ratings reliable? In this article, we'll discuss how to read analyst ratings, what goes into their decision-making process and how potential conflicts of interest influence analyst stock ratings.

What Are Analyst Ratings?

A stock rating is a simple heuristic given by analysts who review the firm's financial statements, listen to conference calls, chat with company executives and compare the stock to others in the industry or sector. Finally, an analyst uses all this information to produce a simple recommendation and price target.

When a public analyst goes on CNBC or the "Wall Street Journal" to give a "buy" or "sell" rating on a particular stock, they take all their research and pare it down into a simple designation. While there's no true consensus on what constitutes a buy or sell rating, an analyst usually does have "skin in the game" when devising ratings.

Ratings often pair with price targets, which put a hard number on what the analysts believe the company stock should be worth. So, for example, you might see an analyst report something like, "Buy NVIDIA Inc. (NASDAQ: NVDA), price target $350," which means that particular analyst believes investors should buy NVDA shares up to a price of $350 per share.

Analyst ratings infographic: What you need to know

What Does a Stock Analyst Do?

A stock analyst is a market professional with the skills to interpret financial data and the connections within companies to speak on the record with higher-ups. Analysts generally fall into one of two different camps: buy-side or sell-side. These positions will seem similar, but they tend to be employed by various institutions and have different responsibilities in their particular market "territories."

Buy-side analysts: Analysts on the buy side tend to work for funds, such as ETF providers or hedge funds. They don't dig as deeply into company financial data or conference calls as sell-siders. Instead, they focus on general areas or industries where their funds have vested interests. In addition, buy-side analysts often forge relationships with sell-side analysts for individual stock research. A buy-side analyst's primary goal is to find and utilize the most accurate and dependable sell-side analysts.
Sell-side analysts: If buy-side analysts work for funds (i.e., institutions that buy securities), you can probably guess which type of institution employs sell-side analysts. Brokers, banks and other firms that sell securities to investors use sell-side analysts to give reports to the public. While buy-side analysts also give ratings and price targets, the reported "buy" and "sell" ratings in financial media typically come from folks on the sell side.

Buy and sell-side analysts often use different rating systems when making their recommendations. You might even find two sell-side analysts with similar "buy" recommendations with vastly different price targets in the same stock. As a result, you'll need to familiarize yourself with the various methodologies analysts use to utilize their research correctly.

What Ratings Do Analysts Give?

Stock analyst ratings don't follow a strict structure, although most have roughly the same grading system for the securities they review. The labels may differ slightly (i.e., overweight vs. outperform), but the five most common analyst ratings go like this.

Buy

Analysts bullish on a particular security will give it a "buy" rating and set a price target above the current market price. In addition, if the analyst considers the stock one of the best in the industry or sector, you'll sometimes see a "strong buy" rating attached.

Hold

A "hold" rating is typically the lowest rating a sell-side analyst gives a stock. "Hold" means the analyst projects the stock to meet the return of the market averages, making it an unspectacular investment. Stocks rated "hold" may still have a price target above the current price, but it's not likely to surpass the return of a major index like the S&P 500.

Sell

Analysts are usually apprehensive about giving a stock a "sell" rating. For example, suppose a "hold" rating indicates indecision over the stock's future. In this scenario, a "sell" rating is issued when an analyst finds something unappealing, such as questionable accounting tactics or cratering sales growth.

Underperform

Analysts won't always give a firm "buy" or "sell" rating on stock but will instead label it "underperform" or "outperform." "Underperform" means the analyst expects the stock not to keep up with the market. It doesn't necessarily mean the analyst predicts a crash but indicates a lack of confidence in the shares.

Outperform

"Outperform" is the opposite of "underperform," meaning the analyst expects the stock to do better than the market average. It's usually considered a less confident rating than "buy."

Example of an Analyst Rating

You can use MarketBeat Analyst Ratings to find ranges and aggregates from buy- and sell-side analysts across the financial media. For example, here's a stock that analysts usually love: Alphabet Inc. (NASDAQ: GOOG).

Overview of stock analysis on GOOG Using MarketBeat's tools, you can find ratings from prominent analysts from multiple periods. Alphabet is currently labeled a "moderate buy" based on MarketBeat's consensus from 17 analysts. You'll get the consensus price target and the highest and lowest from the analysts surveyed.

Marketbeat's tools detailing analyst ratings

Looking at analyst recommendations over time is another helpful tool. For example, you can view the different levels of coverage over the last few years, which analysts changed their ratings and how the price targets vary from month to month. If an analyst can't get a good read on a particular stock they've been covering, they might choose to withhold their grade, which is one reason why the number of available ratings can change over time.

Overview of analyst ratings on MarketBeat Analysts from both sides of the aisle can be found on MarketBeat, ranging from large firms like JPMorgan Chase and Co. (NYSE: JPM) to smaller investment banks like Roth Capital. Some institutions like UBS Group offer both buy-side and sell-side ratings and analysis. These graphs show that even analysts with similar ratings can have vastly different price targets, so always understand the reasoning behind an analyst's view.

How to Use Analyst Ratings

Here are a few pointers on incorporating analyst ratings into your investment research.

Step 1: Don't rely on a single analyst.

Using an array of analysts (buy- and sell-side) gives inventors the most possible information. Don't just look for analysts with similar opinions as yourself — ensure you understand the pros and cons of each investment you make by incorporating positive and negative views, if possible.

Step 2: Compare analyst ratings across the industry or sector.

It's easy to slap a "buy" rating on a stock and predict a winner, but comparing stocks against others in the sector can offer insight into the rating. For example, if a stock is rated "buy" in the information technology sector, but a dozen others are rated "strong buy" by the same analyst, where is your capital best served?

Step 3: Consider your own goals and risk tolerance.

You might find stocks rated "strong buy" in your research in sectors you wish to avoid. That's fine! There are thousands of securities across dozens of industries in the public markets, and you don't need to purchase every share that comes with a "buy" rating. Instead, stick to your investment plan.

Step 4: Don't stubbornly stick to your original assessments.

Following your investment plan and using analyst ratings as guidelines are practical steps, but things can change over time. Today's "strong buy" stocks could be "strong sell" stocks down the road. Using an aggregate of analysts' ratings can help investors view stocks from a higher level. For example, if the number of "buy" ratings on a stock drops 40% over a few years, you might want to take a closer look at that particular company.

Why Are Analyst Ratings Important?

Checking out analyst ratings isn't a necessary step for investing, but it can be helpful for those looking to dig deep into an asset's prospects. Analyst research often has quotes from company executives, questions from conference calls and in-depth reporting on the company's balance sheet, income statement and other essential documents. Analysis like this is complex for individual investors to do on their own, especially considering how frequently analysts interact with the executives they cover. But access often comes with a downside, which we discuss more below.

How Accurate Are Analyst Ratings?

Both buy and sell-side analysts strive for accuracy because giving consistently wrong commendations can be hazardous for job security. However, investors should be aware that analysts might not always have the best interest of the retail investor at heart when making their recommendations.

For starters, being an analyst requires access to company employees and management. Analysts typically ask questions during conference calls and speak with C-suite executives on the record about their firms' prospects. Executives usually don't want to hear adverse reports about their companies, so analysts are incentivized to paint a rosy picture to retain access. The SEC has been questioning the authenticity of analyst ratings (especially on the sell-side) since 2002 when it asked bluntly, "Why are there so few sell ratings?"

Of course, there are other areas of the securities analysis market to face scrutiny. If you recall, during the 2008 financial crisis, the biggest credit rating agencies were all held to the fire due to claims that conflicts of interest influenced their ratings. The biggest rating agencies in the world were accused of "misrepresenting the risks associated with mortgage-backed securities." Remember, analyst ratings aren't spat out by computer algorithms but by living, breathing people who may have agendas other than providing the most precise and accurate reports on a company's future prospects.

Analyst Ratings Can Guide Investors, but Don't Treat Them as Gospel

Consider each type of investment research or advice in collaboration. Even the most accurate and thoughtful analysts get things wrong, plus ratings are frequently besieged with conflicts of interest. But analyst coverage does offer research that's difficult to get elsewhere, and using an array of analyst reports can give investors a deeper understanding of the securities they buy.

FAQs

Still have questions about analyst ratings? Here are a few answers to some common points of discussion:

What are analyst ratings?

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Should you trust analyst ratings?

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

What does an analyst rating tell you about a stock?

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

analyst ratings Headlines

Walgreens agrees to be acquired by private equity firm for almost $10 billion
By The Associated Press | March 6, 2025
View Walgreens agrees to be acquired by private equity firm for almost $10 billion
Investing in Small-Cap AI: Powering the Next Tech Revolution
By Jeffrey Neal Johnson | March 6, 2025
View Investing in Small-Cap AI: Powering the Next Tech Revolution
How major US stock indexes fared Thursday, 3/6/2025
By The Associated Press | March 6, 2025
View How major US stock indexes fared Thursday, 3/6/2025
The Accidental Tech Boom — What AI's Gaming Origins Can Teach Entrepreneurs About Business Breakthroughs
By Entrepreneur | March 6, 2025
View The Accidental Tech Boom — What AI's Gaming Origins Can Teach Entrepreneurs About Business Breakthroughs
'We're Not Effective': Starbucks CEO Tells Corporate Employees to 'Own Whether or Not This Place Grows'
By Entrepreneur | March 6, 2025
View 'We're Not Effective': Starbucks CEO Tells Corporate Employees to 'Own Whether or Not This Place Grows'
6 Steps You Can Take to Set Your Best Budget in 2025
By Entrepreneur | March 6, 2025
View 6 Steps You Can Take to Set Your Best Budget in 2025
Price Targets on NVIDIA Rise in Front of Earnings
By Sarah Horvath | February 24, 2025
View Price Targets on NVIDIA Rise in Front of Earnings

Top Headlines and Offers

View All

March’s Hottest Stocks: 5 Buys to Consider Now
By Thomas Hughes | February 28, 2025
View March’s Hottest Stocks: 5 Buys to Consider Now
Is Advanced Micro Devices Stock Slide Over?
By Thomas Hughes | March 5, 2025
View Is Advanced Micro Devices Stock Slide Over?
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
From Crypto Swap Profits(Ad)
View URGENT: This Altcoin Opportunity Won’t Wait – Act Now
Intuitive Machines: March 6 Is a Pivotal Day for Lunar Economy
By Leo Miller | March 4, 2025
View Intuitive Machines: March 6 Is a Pivotal Day for Lunar Economy
3 Companies Buying Back Stock – Why They’re Doubling Down
By Gabriel Osorio-Mazilli | March 1, 2025
View 3 Companies Buying Back Stock – Why They’re Doubling Down
3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
By Thomas Hughes | March 3, 2025
View 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Shocking Elon Move: Bigger than DOGE?
From Brownstone Research(Ad)
View Shocking Elon Move: Bigger than DOGE?
5 Best Gold ETFs for March to Curb Recession Fears
By Jeffrey Neal Johnson | February 28, 2025
View 5 Best Gold ETFs for March to Curb Recession Fears
Why Smart Investors Are Watching These 3 Undervalued Stocks
By Gabriel Osorio-Mazilli | February 28, 2025
View Why Smart Investors Are Watching These 3 Undervalued Stocks
3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
By Ryan Hasson | March 3, 2025
View 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
Occidental Petroleum Drops to 52-Week Low: Buy, Sell, or Hold?
By Thomas Hughes | March 6, 2025
View Occidental Petroleum Drops to 52-Week Low: Buy, Sell, or Hold?
GitLab: Get In While It’s Down—Big Rebound Ahead
By Thomas Hughes | March 4, 2025
View GitLab: Get In While It’s Down—Big Rebound Ahead

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stock Price Targets and Analyst Ratings